KATHERINE KIVELA: Open Payments
NPI 1609446905 · LATHAM, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,214 in 56 payments from 21 companies in 2025. Trend: 2023 $268 · 2024 $449 · 2025 $1,214
Food & beverage: $1,214
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $341 |
| Abbott Laboratories | 5 | $101 |
| Novo Nordisk Inc | 4 | $100 |
| Lilly USA, LLC | 5 | $99 |
| AstraZeneca Pharmaceuticals LP | 5 | $91 |
| GlaxoSmithKline, LLC. | 4 | $80 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $72 |
| SANOFI-AVENTIS U.S. LLC | 1 | $40 |
| PFIZER INC. | 2 | $38 |
| Lundbeck LLC | 1 | $32 |
Products named: UBRELVY, FREESTYLE LIBRE 3, JARDIANCE, Wegovy, AIRSUPRA, QULIPTA, ZEPBOUND, VRAYLAR.
Industry payments across NY — which companies pay providers there.
